The metabolic signatures of cardiometabolic diseases: Does the shared metabotype offer new therapeutic targets?
Abstract Cardiometabolic diseases (CMDs) are the most common, noncommunicable diseases that claim many lives every year. CMDs have great impact on public health, often driving the attention of healthcare resources to prevent and treat them. CMDs include cardiovascular diseases, type 2 diabetes melli...
Saved in:
Main Author: | Arwa M. Amin (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Implications of Metabotypes for Rationalizing Therapeutics in Infants and Children
by: Theodora eKatsila, et al.
Published: (2015) -
Does the "no" to death offer the "yes" to therapeutic obstination?
by: Karla Cristiane Oliveira Silva, et al.
Published: (2012) -
Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases
by: Chao Li, et al.
Published: (2020) -
Metabolipidomic Analysis in Patients with Obstructive Sleep Apnea Discloses a Circulating Metabotype of Non-Dipping Blood Pressure
by: Lucía Pinilla, et al.
Published: (2023) -
A new metabolic signature to predict melanoma recurrence
by: Ngan K. Vu, et al.
Published: (2024)